Neurology News

Patients hospitalized for COVID-19 infection and those who survived other severe acute respiratory infections were at similarly higher risk for subsequent neuropsychiatric diagnoses and treatment, researchers reported in JAMA Psychiatry.

Wysa announced it has received breakthrough device designation from the FDA for its artificial intelligence-based digital mental health conversational agent for adults with chronic musculoskeletal pain, depression and anxiety.

The FDA has approved Radicava ORS oral suspension for the treatment of adults with ALS.

Neurotechnology firm Kernel and biopharmaceutical company Cybin announced promising pilot results from a feasibility study of Kernel Flow, a technology that measures brain activity in altered states of consciousness.

Positive airway pressure therapy may delay cognitive decline in adults with obstructive sleep apnea, but more research is needed, according to a systematic review published in Neurology.

Stealth BioTherapeutics Corp. announced that the FDA has granted orphan drug designation to elamipretide for the treatment of Duchenne muscular dystrophy.

People with higher levels of narcissism were less likely to follow COVID-19 mitigation strategies, such as masking and vaccination, researchers reported in Current Psychology.

Implementation of an interactive training program increased clinician adherence to stroke guidelines and reduced the proportion of disabled or deceased patients with acute ischemic stroke, researchers reported in JAMA Network Open.

Suicidal ideation appears similar between gun owners and non-gun owners when the probability of suicide is low, but when the probability rises, gun owners were less likely to endorse active means, researchers reported in JAMA Network Open.

People with higher levels of antioxidants in their blood may be less likely to develop dementia, researchers reported in Neurology.